Flatiron Health was purchased by Roche, the Swiss drug giant, for $1.9 billion in February. At the time, the New York startup said that it would still be open for business with other drug companies. It wasn’t kidding.
Flatiron Health was purchased by Roche, the Swiss drug giant, for $1.9 billion in February. At the time, the New York startup said that it would still be open for business with other drug companies. It wasn’t kidding.